Waist circumference, but not body mass index, is a predictor of ventricular remodeling after anterior myocardial infarction

Nutrition

Volumn 29, Issue 1, 2013, Pages 122-126

  Cogni, Ana Lucia ^a   Farah, Elaine ^a   Minicucci, Marcos F ^a   Azevedo, Paula S ^a   Okoshi, Katashi ^a   Matsubara, Beatriz B ^a   Zanati, Silméia G ^a   Paiva, Sergio A R ^a   Zornoff, Leonardo A M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Coronary occlusion; Ischemia; Obesity; Prognosis; Ventricular dilatation

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB;

ADULT; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DECELERATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE;

AGED; BODY MASS INDEX; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; VENTRICULAR REMODELING; WAIST CIRCUMFERENCE;

EID: 84870833953     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.04.020     Document Type: Article

References (35)

1. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
2. Rosamond W., Chambless L.E., Folson A.R., Cooper L.S., Conwill D.E., Clegg L., et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998, 339:861-867.
3. Turpie A.G.G. Anticoagulants in acute coronary syndromes. Am J Cardiol 1999, 84(suppl):2M-6M.
4. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 1995, 91:1659-1668.
5. Risk stratification and survival after myocardial infarction. N Engl J Med 1983, 309:331-336. The Multicenter Postinfarction Research Group.
6. Mahon N.C., O'Rorke C., Codd M.B., McCann H.A., McGarry K., Sugrue D.D. Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart 1999, 81:478-482.
7. Mill J.G., Stefanon I., Santos L., Baldo M.P. Remodeling in the ischemic heart: the stepwise progression for heart failure. Braz J Med Res 2001, 44:890-898.
8. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
9. Zornoff L.A.M., Paiva S.A.R., Duarte D.R., Sparado J. Ventricular remodeling after myocardial infarction: concepts and clinical implications. Arq Bras Cardiol 2009, 92:157-164.
10. Apovian C.M., Gorke N. Obesity and cardiovascular disease. Circulation 2012, 125:1178-1182.
11. Iakobishvili Z., Danicek V., Porter A., Assali A.R., Battler A., Hasdai D. Is increased body mass index associated with a cardioprotective effect after ST-segment-elevation myocardial infarction?. Acute Card Care 2006, 8:95-98.
12. Mehta R.H., Califf R.M., Garg J., White H.D., van de Werf F., Armstrong P.W., et al. The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J 2007, 28:415-424.
13. Zeller M., Steg P.G., Ravisy J., Lorgis L., Laurent Y., Sicard P., et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 2008, 118:482-490.
14. Wu A.H., Pitt B., Anker S.D., Vincent J., Mujib M., Ahmed A. Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age. Eur J Heart Fail 2010, 12:566-573.
15. Eisenstein E.L., McGuire D.K., Bhapkar M.V., Kristinsson A., Hochman J.S., Kong D.F., et al. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. Am J Med 2005, 118:981-990.
16. Wells B., Gentry M., Ruiz-Arango A., Dias J., Landolfo C.K. Relation between body mass index and clinical outcome in acute myocardial infarction. Am J Cardiol 2006, 98:474-477.
17. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
18. Huxley R., Mendis S., Zheleznyakov E., Reddy S., Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature. Eur J Clin Nutr 2010, 64:16-22.
19. Welborn T.A., Dhaliwal S.S. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007, 61:1373-1379.
20. Chouraki V., Wagner A., Ferrières J., Kee F., Bingham A., Haas B., et al. Smoking habits, waist circumference and coronary artery disease risk relationship: the PRIME study. Eur J Cardiovasc Prev Rehabil 2008, 15:625-630.
21. Libhaber C.D., Norton G.R., Majane O.H.I., Libhaber E., Essop M.R., Brooksbank R., et al. Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity. Am J Cardiol 2009, 104:1527-1533.
22. Fisher L.D., Belle G.V. Biostatistics: a methodology for health science 1993, John Wiley, New York.
23. Cornier M.-A., Després J.-P., Davis N., Grossniklaus D.A., Klein S., Lamarche B., et al. Assessing adiposity. A scientific statement from the American Heart Association. Circulation 2011, 124:1996-2019.
24. Pfeffer M.A., McMurray J.J., Velazquez E.J., Rouleau J.L., Køber L., Maggioni A.P., et al. Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003, 349:1893-1906.
25. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
26. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002, 106:3143-3421.
27. Udelson J.E., Konstam M.A. Ventricular remodeling: fundamental to the progression (and regression) of heart failure. J Am Coll Cardiol 2011, 57:1477-1479.
28. Lang R.M., Bierig M., Devereaux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
29. Sun Y. Myocardial repair/remodeling following infarction: roles of local factors. Cardiovasc Res 2009, 81:482-490.
30. Alexander J.K. Chronic heart disease due to obesity. J Chronic Dis 1965, 18:895-898.
31. Litwin S.E. Cardiac remodeling in obesity. JACC Cardiovasc Imaging 2010, 3:275-277.
32. Turkbey E.B., McClelland R.L., Kronmal R.A., Burke G.L., Bild D.E., Tracy R.P., et al. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging 2010, 3:266-274.
33. Wong C.Y., O'Moore-Sullivan T., Leano R., Byrne N., Beller E., Marwick T.H. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004, 110:3081-3087.
34. DeMarco V.G., Johnson M.S., Whaley-Connell A.T., Sowers J.R. Cytokine abnormalities in the etiology of the cardiometabolic syndrome. Curr Hypertens Rep 2010, 12:93-98.
35. Elks C.M., Francis J. Central adiposity, systemic inflammation, and the metabolic syndrome. Curr Hypertens Rep 2010, 12:99-104.